Strategic CEO - Antifibrotic Drug Leader

CRSI; United Kingdom; On-site; GBP 120,000 - 180,000; Full time

Job summary

A biopharmaceutical company is seeking a CEO to lead the strategic vision, drive clinical milestones, and secure funding for the TG2 inhibitor. The ideal candidate will have strong leadership skills, experience in investor relations, and a solid understanding of clinical trial processes. This role includes overseeing Phase 1 trials and building a high-performing team, essential for navigating the antifibrotic market. The company requires strategic insight to enhance its presence and overcome regulatory challenges.

Qualifications

• Proven experience in strategic leadership roles within the pharmaceutical or biotechnology industry.
• Expertise in managing investor relationships and securing funding.
• Experience with clinical trial oversight and market entry strategies.

Responsibilities

• Lead the licensing and market entry of the TG2 inhibitor.
• Oversee Phase 1 clinical trials and additional funding efforts.
• Develop and execute the company's strategic vision and position in the antifibrotic market.

Skills

Investment Management

Strategic Leadership

Team Building

Market Entry Strategy

Clinical Trial Oversight

Job description

A biopharmaceutical company is seeking a CEO to lead the strategic vision, drive clinical milestones, and secure funding for the TG2 inhibitor. The ideal candidate will have strong leadership skills, experience in investor relations, and a solid understanding of clinical trial processes. This role includes overseeing Phase 1 trials and building a high-performing team, essential for navigating the antifibrotic market. The company requires strategic insight to enhance its presence and overcome regulatory challenges.